Evidence map›Paper›PMID 23929105›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2013

Mitochondria-targeted antiaging gene therapy with adeno-associated viral vectors.

Dejia Li, Dongsheng Duan

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Dejia LiDepartment of Occupational Environmental Health, School of Public Health, Wuhan University, Wuhan, People's Republic of China.
Dongsheng Duan
University of Missouri · USWuhan University · CN

Funding

Dual AAV Vectors for Duchenne Muscular Dystrophy TherapyR01AR049419 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI DUAN, DONGSHENG · 2003 to 2012
$4.1M
NIAMS NIH HHS AR-49419NIAMS NIH HHS R01 AR049419
6 · The paper itself

Abstract

Transgenic expression of catalase in mitochondria using a transgenic strategy extends life span and prevents aging-related pathology in mice. However, transgenic overexpression is not suitable for a clinical application. Adeno-associated virus (AAV) is the most promising gene delivery vehicle. Here we outline strategies on the generation of an AAV vector expressing the mitochondria-targeted catalase gene (AV.RSV.MCAT). We also describe methods for evaluating physiological impact of AV.RSV.MCAT on muscle contractility and running performance in mice.

Indexed as

Gene Transfer TechniquesAgingAnimalsCatalaseCell LineDependovirusGenetic TherapyGenetic VectorsHEK293 CellsHumansMiceMice, Inbred C57BLMitochondriaMotor ActivityMuscle ContractionReactive Oxygen SpeciesCatalaseReactive Oxygen Species

Identifiers

PMID23929105
PMCPMC4539949
OpenAlexW2403345662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.